CD38 and chronic myelogenous leukemia, BCR-ABL1 positive: Acquisition of such genetic alteration transforms a normal Lin–CD34+CD38– HSC into a CML-initiating cell/leukemia stem cell, with a proliferative advantage and bias toward myeloid differentiation (62, 150).